Myoma;Uterus Clinical Trial
— ENDORA2Official title:
Evaluation of the Feasibility of Using Augmented Reality in Laparoscopic Surgery, by a Clinical Study During Gynecological Laparoscopic Surgical Procedures.
Augmented Reality is a technology that allows surgeons to superimpose virtual images from preoperative imaging onto the endoscopic vision system intraoperatively. The goal of this clinical trial is to demonstrate that the use of augmented reality during laparoscopic gynecological surgery with a dedicated device could provide assistance to the surgeon, in terms of technical comfort and better visualization of the benign tumor to be resected on a mobile organ.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | March 29, 2024 |
Est. primary completion date | February 29, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 84 Years |
Eligibility | Inclusion Criteria: - Aged between 18 (included) and 84 (included), - Patient with intrauterine myoma, with indication for surgical management by laparoscopic myomectomy, or uterine pathology with indication for surgical management by laparoscopic hysterectomy, - Patient affiliated or beneficiary of a health insurance scheme, - Patient agreeing to participate in the study after having received the written information document and signed the consent form. Exclusion Criteria: - Patients under 18 or over 84 years of age, - Patients with contraindications to MRI (pacemaker, ocular metal splinters, etc.), - Impossibility of planned surgery, - Patient with endometrial cancer contraindicating laparoscopic surgery, - Known pregnant or breast-feeding patient, - Patient of legal age, under guardianship or curatorship, - Patients whose regular follow-up is impossible for geographical, psychological, family or social reasons (these reasons will be collected). |
Country | Name | City | State |
---|---|---|---|
France | Polyclinique Urbain V | Avignon | |
France | CHU Clermont-Ferrand | Clermont-Ferrand | |
France | CHU de Saint-Étienne | Saint-Étienne |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The feasibility of augmented reality will be measure using the SURG-TLX scale | The feasibility of the technique will be considered satisfactory if the SURG-TLX score given by the surgeon at the end of the procedure is less than or equal to 33.7 (threshold defined by experts). | In the intra-operative phase of the study | |
Secondary | Score of the surgeon's performance in using the augmented reality device | Measuring the performance-related score when using the augmented reality device by filling in a scale. | In the intra-operative phase of the study | |
Secondary | Collection of operative time | Collection of operating times for the entire surgery, as well as the various times associated with augmented reality device installation. | In the intra-operative phase of the study | |
Secondary | Number of device failures during surgery | Number of device failures during surgery (defined as an abrupt stop of the device during its use) | In the intra-operative phase of the study | |
Secondary | Number of failures to start up the software | Collection of the number of failures to set up the augmented reality device | In the intra-operative phase of the study | |
Secondary | Collection of the real direct medical costs of the procedure from an institutional point of view. | Collection of the real direct medical costs of the procedure from an institutional point of view. | From the date of the surgery to the date of the first post-operative visit, usually 1 month after the surgery | |
Secondary | Number of laparoscopic/laparotomy conversions | Collection of the number of laparoscopic/laparotomy conversions. | In the intra-operative phase of the study | |
Secondary | Number of intraoperative and postoperative complications | Collection of the number of intraoperative and postoperative complications (especially vascular or ureteral wounds). | From the date of the surgery to the date of the first post-operative visit, usually 1 month after the surgery | |
Secondary | Quantification of bleeding | Collection of bleeding volume during the surgery. | In the intra-operative phase of the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Active, not recruiting |
NCT06114758 -
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
|
||
Not yet recruiting |
NCT05932082 -
The Impact of Myomectomy on IVF Outcomes
|
N/A | |
Not yet recruiting |
NCT05967936 -
Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy
|
N/A | |
Recruiting |
NCT04748978 -
OPPIuM Technique and Myolysis With Diode Laser Dwls
|
N/A | |
Recruiting |
NCT05271981 -
Fertility After Uterine Artery Embolization
|
||
Completed |
NCT05025410 -
Remimazolam and Remifentanil Without Neuromuscular Blocking Agent
|
||
Recruiting |
NCT03483142 -
the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation
|
Phase 3 | |
Completed |
NCT03533907 -
Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
|
||
Completed |
NCT05811286 -
The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study
|
N/A | |
Not yet recruiting |
NCT03570879 -
Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.
|
||
Not yet recruiting |
NCT04364581 -
Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions
|
Phase 4 | |
Recruiting |
NCT04990076 -
Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
|
||
Recruiting |
NCT06325501 -
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy
|
Phase 3 | |
Completed |
NCT05761418 -
Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy
|
Phase 3 | |
Recruiting |
NCT04311073 -
Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies
|
Phase 3 | |
Active, not recruiting |
NCT05930769 -
Retrospective Study on the Evaluation of the Impact of Augmented Reality Usage in Gynecological Laparoscopy on Patients Operated Between 2017 and 2021 (ImpactRA)
|
||
Recruiting |
NCT03550703 -
Open Label Immunotherapy of Myoma
|
Phase 2 | |
Completed |
NCT04482959 -
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
|
Phase 4 | |
Not yet recruiting |
NCT04030273 -
Prevalence of Intrauterine Adhesions After Abdominal Myomectomy
|